The Fragile Core: Healthcare’s IoT Revolution and the Risk of Systemic Breach
The Infrastructure of Care Is Not Neutral In a modern hospital, the patient is never truly alone. Surrounding them are ...
Signals and Symptoms: The Diagnostic Future of AI and Wearable Technology
The Disappearance of the Waiting Room Until recently, diagnosis in medicine occurred primarily in discrete moments—a scheduled visit, a test ...
Outbreak by Choice: The Resurgence of Measles and the Erosion of Vaccine Consensus
An Old Virus Finds New Ground In 2000, the Centers for Disease Control and Prevention declared measles eliminated from the ...
Seasonal Surveillance: COVID’s Summer Resurgence, RSV Breakthroughs, and the Return of Treatable Infections
Epidemiology by the Season Public health, long characterized by its slow-moving cycles of surveillance and response, has become an increasingly ...
Cold Storage and Hot Zones: How Japan’s Universal Artificial Blood May Transform Global Medicine
A Solution 80 Years Overdue Since the first wartime plasma transfusions in the 1940s, blood has remained a biologically necessary, ...
Viral Prescriptions: How Social Media Is Quietly Redefining Health Decision-Making
The Algorithm Advises Rest and Lemon Water In an environment of infinite scroll, where emotional resonance often outpaces scientific rigor, ...
Performative Oncology: The Rise of Cancer Influencers and the Erosion of Evidence
The Spectacle of Sickness There is a calculated rhythm to the videos. A grainy close-up of someone solemnly describing their ...
The Algorithm Will See You Now: TikTok’s Role in Rewriting Mental Health Discourse
The Algorithm is Listening. It Just Isn’t Learning. The images flicker in succession: a young woman tearfully recounts her trauma ...
Visible Scars, Invisible Standards: Breast Reduction and the Online Reckoning with Body Image
The Body as Algorithmic Subject The footage begins plainly. A montage of clothing struggles, physical discomfort, and slouched posture. The ...
Surveillance in Scrubs: How Patient Filming in Medical Settings Challenges Ethics, Privacy, and Care Delivery
Lights, Camera, Confidentiality? A patient lifts their phone and starts recording. The nurse, midway through a blood draw, hesitates. The ...
Purge at the CDC: How RFK Jr.’s Vaccine Shake-Up Opens a New Front in America’s Culture War
Seventeen careers ended with a single memo—an unprecedented eviction notice that turned a sleepy bureaucratic panel into the hottest battleground ...
Feeding Remission: How Anti-Inflammatory Diets Are Quietly Boosting Colorectal-Cancer Survival
The IV pump clicks off, the chemo port is flushed—and what you choose for dinner may now matter as much ...
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more